Stanislas Conseiller Congratulates Humbert Marc on Receiving the INSERM 2025 Grand Prize
Stanislas Conseiller, Philanthropy and Fundraising Development Officer at Faculté de Médecine Paris-Saclay, shared on LinkedIn:
”The Inserm Grand Prize shines a light on one man and his career… but also on an entire French model.
I would like to pay tribute to all those doctors, researchers, professors, and university hospital staff who combine three vocations in one: caring, understanding, and passing on knowledge.
These are women and men who, often far from the spotlight, support our healthcare system, train future generations, and advance science with remarkable determination.
As true pillars of our system and of medical innovation, they embody what is most precious in our medicine: generosity and excellence in the service of all.
It is in this spirit that I would like to warmly congratulate Humbert Marc, Dean of the Paris-Saclay Faculty of Medicine, on winning the INSERM 2025 Grand Prize, one of the highest distinctions in biomedical research in France.
This award crowns more than thirty years of commitment to patients with pulmonary arterial hypertension (HTAP).
Together with his teams, Marc Humbert has helped transform the understanding and management of this rare disease: creation of a national registry, major advances in basic and clinical research, development of new therapeutic approaches, and more.
This remarkable work has significantly improved patients’ life expectancy and quality of life.
Although I joined the faculty only a year ago, every day I appreciate how fortunate I am to be working alongside these exceptional individuals, who are doctors, researchers, and teachers.
They maintain a unique link between care, training, and research, benefiting patients, students, and society as a whole.
Congratulations to him, and thank you to all those who, on a daily basis, bring to life this generous, open, and ambitious vision of university hospital medicine.
As for us “laypeople,” let us admire and support this model to which we owe so much.”
More winner stories featured in Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis